Vioxx Prompts Consumer Group To Call For Drug Safety Overhaul
221685
The Consumers Union is calling on the Food and Drug Administration (FDA) to implement measures to improve prescription drug safety and transparency.
704207
Those on Vioxx were 2.7 times likelier to have a problem, but an expert questions the safety of the entire class of painkillers. By Amanda Gardner.
415386
The recall of Merck&#39;s arthritis drug Vioxx has drawn attention to drug overall safety, more specifically, a similar drug known as Celebrex, by the drug maker Pfizer.
305432
Our position is: Greater drug safety needs to be coupled with awareness that some risk is inherent in medicine. When it comes to assurances of drug safety, consumers would be advised to heed George Bernard Shaw&#39;s warning to beware of what they wish for.
159888
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way it monitors safety risks associated with medicines already  on the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
680573
European medicines watchdogs are to consider whether doctors need more warnings about the use of a drug to treat rheumatoid arthritis after an alert in the US by its manufacturers.
23664
Merck &amp; Co. Inc. Chief Executive Officer Raymond Gilmartin and FDA officials have been called to testify before Congress on Nov. 18 over safety problems with the company&#39;s withdrawn
128777
A top Republican lawmaker called Wednesday for Merck &amp; Company to answer questions about its withdrawn drug Vioxx on Nov. 18 at the first Congressional hearing to address the drug&#39;s safety problems.
78305
The U.S. Food and Drug Administration needs to more closely regulate direct-to-consumer advertising of prescription drugs, the Government Accountability Office said on Thursday.
205695
The US Food and Drug Administration on Friday asked an outside group to review the way it monitors safety risks associated with medicines already on the market, such as Merck &amp; Co.
137276
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way the agency monitors safety risks of medicines after they  hit the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
236669
With yet more already-marketed medicines raising the ire of consumer advocates and regulators alike, momentum is building for reform of the governmentâs drug approval and monitoring procedures.
518488
The US regulator to beef up monitoring of drug safety after criticism over a painkiller linked to heart disease.
35159
Government drug-buying agency Pharmac wants drug companies to act more swiftly when concerns are raised over potential side-effects of their drugs, and to be responsible in promoting their products.
393977
The U.S. Food and Drug Administration said on Tuesday it would make organizational changes to improve internal communication about potential risks that emerge after a new drug reaches the market.
12791
Arguing that the country&#39;s system for monitoring drug safety is haphazard and ineffectual, editors of a leading medical journal Monday called for a radical overhaul and suggested the creation of a new independent drug safety board.
326837
Last weekâs dramatic withdrawal of the COX-2 inhibitor rofecoxib (Vioxx) is discussed in this weekâs lead editorial in THE LANCET, which comments that more vigilant drug licensing is vital to prevent the endangering of patientsâ health.